April 23 (Bloomberg) -- William Isaacson, partner at Boies, Schiller & Flexner LLP, talks with Bloomberg Law's Spencer Mazyck about his eight-year antitrust crusade against several Chinese Vitamin C makers, which resulted in a federal jury verdict on March 14, 2013, ordering the manufacturers to pay $162.3 million to U.S. customers for fixing export prices. This case marks the first time Chinese companies faced a trial on U.S. antitrust claims.
Isaacson, in this "Rainmakers" episode, also discusses the implications of the historic ruling for Chinese companies doing business in the United States.
(Source: Bloomberg)
